Actinium Pharmaceuticals
ATNM
#9124
Rank
ยฃ46.35 M
Marketcap
ยฃ1.49
Share price
4.92%
Change (1 day)
-58.81%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -ยฃ37.31 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.08 Million. In 2023 the company made an earning of -ยฃ40.19 Million a decrease over its 2022 earnings that were of -ยฃ26.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ37.31 Million-7.17%
2023 -ยฃ40.19 Million52.24%
2022 -ยฃ26.4 Million36.61%
2021 -ยฃ19.33 Million11.48%
2020 -ยฃ17.34 Million1.46%
2019 -ยฃ17.09 Million-7.37%
2018 -ยฃ18.45 Million-11.46%
2017 -ยฃ20.83 Million10.67%
2016 -ยฃ18.82 Million15.7%
2015 -ยฃ16.27 Million-14.86%
2014 -ยฃ19.11 Million129.19%
2013 -ยฃ8.34 Million-8.55%
2012 -ยฃ9.12 Million
2010 ยฃ0 M-152.15%
2009 -ยฃ0.02 Million-39.8%
2008 -ยฃ0.03 Million120.29%
2007 -ยฃ0.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ28.79 Million-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.30 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ77.27 Million 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA